Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Kaplan Fox Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of a Securities Class Action Deadline on October 14, 2025
Via TheNewswire.com
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Kaplan Fox Reminds Unicycive Therapeutics, Inc. (UNCY) Investors of a Securities Class Action Deadline on October 14, 2025
Via NewMediaWire
Topics Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
FDA Rejects Outlook Therapeutics Eye Drug For Second Time
Via Benzinga
Tickers AMD OTLK
Exposures Product Safety
Simona Ballard Calls for Greater Transit Worker Safety and Public Awareness
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Ford Recalls Nearly Half A Million Vehicles In The US – More Details Inside
Via Stocktwits
Topics Product Recall
Tickers F
Exposures Legal Product Safety
Pfizer, BioNTech Get FDA Clearance For Updated Covid Vaccine In Senior Adults And Younger At-Risk Population
Via Stocktwits
Tickers BNTX MRNA PFE
Exposures COVID-19 Product Safety
FDA Approves First-Ever Generic Weight-Loss Drug In A Blow To Novo Nordisk
Via Investor's Business Daily
Tickers NVO TEVA
Exposures COVID-19 Product Safety
Nicolas Verderosa Is Bringing Rural Italy Back to the Global Stage With Ruralis
Via Get News
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at Three September Investor Conferences
Via Investor Brand Network
Topics Intellectual Property
Tickers BEAT
Exposures Intellectual Property Product Safety
Travere Flirts With A Breakout As FDA Decision Bolsters Filspari's Launch
Via Investor's Business Daily
Tickers TVTX
Exposures Product Safety
Investors in Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Investors in Unicycive Therapeutics, Inc. Should Contact Levi &amp; Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Capricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Class Action Filed Against Replimune Group, Inc. (REPL) Seeking Recovery for Investors - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Capricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi &amp; Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Class Action Filed Against Replimune Group, Inc. (REPL) Seeking Recovery for Investors - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Nicolas Verderosa Is Bringing Rural Italy Back to the Global Stage With Ruralis
Via Press Release Distribution Service
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
If You'd Invested $1,000 in IOVA 3 Years Ago, Here's How Much You'd Have Today
Via The Motley Fool
Tickers IOVA
Exposures Product Safety
Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
Tickers AMZN BEAM BMY CCJ CEG CRSP
Exposures Artificial Intelligence Economy Electricity Generation
OS Therapies to Provide OST-HER2 Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma FDA End of Phase 2 Meeting Update on Tuesday, September 2, 2025
Via Newsfile
Tickers OSTX
Exposures Product Safety
RFK Jr. Rescinds Emergency Authorizations For COVID-19 Vaccines
Via Benzinga
Tickers BNTX MRNA NVAX PFE
Exposures COVID-19 Product Safety
Navigating the Currents: Top Sectors Primed for Growth in Q3 2025
Via MarketMinute
Topics Artificial Intelligence Economy Retirement
Tickers ABT AMZN BAC BEP BRK-A BRK-B
Exposures Artificial Intelligence Economy Fossil Fuels
Robert Kennedy Jr. Announces End Of FDA Covid Mandates – Clears Moderna, Pfizer, Novavax For High-Risk Groups
Via Stocktwits
Tickers MRNA NVAX PFE
Exposures COVID-19 Product Safety
BioXcel Seeks FDA Label Expansion For Schizophrenia Treatment
Via Benzinga
Tickers BTAI
Exposures Product Safety
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces Expanded Access Policy for NRX-100 Following FDA Fast Track Designation
Via Investor Brand Network
Tickers NRXP
Exposures Product Safety
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers UNCY
Exposures Financial Legal Product Safety
Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) - September 15, 2025 Deadline to Join - Contact Levi & Korsinsky
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Investors in Replimune Group, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) - September 15, 2025 Deadline to Join - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Investors in Replimune Group, Inc. Should Contact Levi &amp; Korsinsky Before September 22, 2025 to Discuss Your Rights - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.